Dr RR Baliga's "Got Knowledge Doc" Podkast

A fascinating new study reveals a previously underappreciated pathway for tau clearance in the brain.

Researchers show that tanycytes—specialized hypothalamic glial cells—actively transport tau from cerebrospinal fluid into the bloodstream. In Alzheimer disease, these cells become fragmented and dysfunctional, impairing tau clearance and potentially accelerating neurodegeneration.

This work opens an intriguing avenue: could restoring tanycyte function enhance tau removal and slow Alzheimer progression?

A small cellular gatekeeper may hold an important clue in the battle against dementia.

Source: Sauvé F et al. Tanycytic degeneration impairs tau clearance and contributes to Alzheimer's disease pathology. Cell Press Blue, 2026.

Obesity is not simply excess weight—it is a metabolic and inflammatory state that can reshape cancer biology.

Adipose tissue alters hormones, insulin signaling, inflammatory cytokines, and immune responses, creating conditions that favor tumor development.

Evidence now links obesity with cancers of the breast, colon, endometrium, pancreas, liver, kidney, and esophagus.

Understanding these mechanisms opens the door to precision prevention strategies, from weight management to metabolic therapies.

The message from translational science is clear: metabolism and malignancy are deeply intertwined.

#CancerResearch #ObesityScience #TranslationalMedicine

🧬 Apolipoprotein M (ApoM) is emerging as a key regulator of vascular biology.

ApoM, an HDL-associated lipocalin, transports sphingosine-1-phosphate (S1P) and selectively activates S1PR1 signaling in endothelial cells.

This pathway stabilizes the endothelial barrier, promotes nitric-oxide mediated vasodilation, and suppresses vascular inflammation.

Clinical studies increasingly link lower ApoM levels with cardiometabolic disease, CKD, and heart failure risk.

New therapies—including ApoM-fusion biologics and selective S1PR1 agonists—may harness this pathway for vascular protection.

The ApoM–S1P axis may represent a new frontier in precision cardiovascular medicine.

📚 Simone de Beauvoir (1908–1986) — philosopher, writer, and architect of modern feminism.

Her groundbreaking book The Second Sex (1949) reshaped global conversations on gender with one powerful line:

"One is not born, but becomes, a woman."

She challenged stereotypes, defended women's autonomy, and influenced second-wave feminism worldwide.

Her ideas still echo in medicine, education, ethics, and leadership today.

Freedom. Responsibility. Equality. 💡✊📖

🫁 Pulmonary Embolism in 2026 — A Precision Framework

The new AHA/ACC Acute Pulmonary Embolism Guideline redefines how we classify and treat PE.

Key updates:

• Category A–E clinical classification integrating hemodynamics, biomarkers, and RV imaging

• Age-adjusted D-dimer and YEARS algorithm to reduce unnecessary imaging

• CT pulmonary angiography as preferred diagnostic modality

• RV/LV ratio reporting for objective risk stratification

• LMWH → DOAC preferred for anticoagulation

• Advanced therapies for cardiopulmonary failure

• Mandatory 1-year follow-up to screen for CTEPD

The message is clear: Stratify early. Treat precisely. Monitor longitudinally.

🧬✨ Can we make the ageing immune system young again?

A fascinating Nature study shows that a three-part mRNA cocktail (DFI) can temporarily rejuvenate T cells in aged mice, improving responses to vaccines and cancer immunotherapy—without breaking immune tolerance. By turning the liver into a short-term factory for key immune signals (DLL1, FLT3L, IL-7), the authors demonstrate that immune ageing is modifiable, not fixed.

This elegant work—covered by Heidi Ledford in Nature—opens provocative questions about immune resilience, ageing biology, and the future of mRNA beyond vaccines. 🧠🛡️

📄 Friedrich MJ et al., Nature 2025 | News & Views: Ledford H.

🔗 doi:10.1038/s41586-025-09873-4 | doi:10.1038/d41586-025-04082-5

Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting ~37.6 million people globally, with prevalence expected to double in the coming decades.

A recent Lancet Seminar (2026) highlights several key principles shaping modern AF care:

• Stroke prevention with oral anticoagulation remains the cornerstone

• Early rhythm control strategies improve cardiovascular outcomes

• Catheter ablation is increasingly used as first-line therapy

• Lifestyle modification—weight loss, exercise, alcohol reduction—reduces AF burden

• Integrated care models such as the ABC pathway and AF-CARE improve outcomes

The future of AF management is holistic, preventive, and patient-centred.

#Cardiology #AtrialFibrillation #StrokePrevention #Electrophysiology #PrecisionMedicine

🧬 Protein Restriction, Aging, and Longevity ⏳

A remarkable new study in Cell shows that moderate protein restriction—especially when started in midlife—can reprogram aging biology across 41 organs, improving metabolic and cardiovascular health. 🫀⚙️

Using deep multi-organ proteomics in mice and human plasma validation, the authors demonstrate benefits mediated through ↓ IGF-1, ↓ mTOR, ↑ AMPK, and activation of brown adipose tissue. Importantly, the data also caution that extreme protein restriction may provoke inflammation, underscoring that moderation matters. ⚠️🎯

A powerful example of how nutrition shapes the biology of aging—organ by organ, pathway by pathway.

📖 Cell (2025)

#Aging #Longevity #ProteinRestriction #MetabolicHealth #CardiovascularHealth #Proteomics #PrecisionNutrition

Resistant hypertension remains one of the most stubborn challenges in cardiovascular medicine.

The Bax24 phase 3 trial, published in The Lancet (2026), evaluated baxdrostat, a selective aldosterone synthase inhibitor, in patients already receiving multiple antihypertensive agents.

Key findings:

• −16.6 mmHg reduction in 24-hour ambulatory SBP

• −14.0 mmHg placebo-corrected difference (p

• 71% achieved BP control (

• Acceptable safety profile, with hyperkalemia in 3%

These data highlight the growing importance of aldosterone dysregulation in resistant hypertension and suggest that targeted aldosterone synthase inhibition may represent a new therapeutic frontier.

Reference: Azizi M et al. Effect of Baxdrostat on Ambulatory Blood Pressure in Resistant Hypertension (Bax24). Lancet 2026.

🏃‍♀️🏋️‍♂️ Does variety in physical activity matter for longevity? A large prospective analysis suggests it does: people who engaged in a wider mix of activity types tended to have lower all-cause mortality, even after accounting for total activity and key covariates. 🌈📉

Key practical takeaway: don't just "do more"—do different (walk + cycle + swim + strength, etc.). ✅🫀

As always, this is observational data (residual confounding + self-report remain). Still, it's a compelling nudge toward diversity in movement as a realistic, patient-friendly goal. 💡👟

#PhysicalActivity #Prevention #Cardiology #PublicHealth #LifestyleMedicine